The initial success of Viagra undeniably revolutionized the drug landscape, but investing in companies strongly reliant on unbranded versions presents a uncertain picture. Despite early profits were substantial, the cessation of patents and the appearance of less expensive alternatives have weakened the customer base. Therefore, a thorough evaluati